High variability in self-pay pricing for vasectomy and vasectomy reversal in the United States.

IF 3.4 2区医学 Q1 DEMOGRAPHY

Perspectives on Sexual and Reproductive Health Pub Date : 2024-06-01 Epub Date: 2024-05-23 DOI:10.1111/psrh.12266

Aaron Brant, Patrick Lewicki, Alec Zhu, Stephen Rhodes, Camilo Arenas-Gallo, Jonathan E Shoag, Peter N Schlegel, Joshua Halpern

{"title":"High variability in self-pay pricing for vasectomy and vasectomy reversal in the United States.","authors":"Aaron Brant, Patrick Lewicki, Alec Zhu, Stephen Rhodes, Camilo Arenas-Gallo, Jonathan E Shoag, Peter N Schlegel, Joshua Halpern","doi":"10.1111/psrh.12266","DOIUrl":null,"url":null,"abstract":"Context: In the United States (US) men who undergo vasectomy and/or vasectomy reversal (vasovasotomy) are likely to pay out-of-pocket for these procedures. We characterized the publicly disclosed pricing of both procedures with a focus on variability in self-pay prices.Methods: We queried all US hospitals for publicly disclosed prices of vasectomy and vasovasotomy. We assessed interhospital variability in self-pay pricing and compared hospitals charging high (≥75th percentile) and low (≤25th percentile) self-pay prices for either procedure. We also examined trends in pricing after the 2022 US Supreme Court decision that allowed individual states to ban abortion.Results: Of 6692 hospitals, 1375 (20.5%) and 281 (4.2%) disclosed self-pay prices for vasectomy and vasovasotomy, respectively. There was a 17-fold difference between the 10th and 90th percentile self-pay prices for vasectomy ($421-$7147) and a 39-fold difference for vasovasotomy ($446-$17,249). Compared with hospitals charging low (≤25th percentile) self-pay prices for vasectomy or vasovasotomy, hospitals charging high (≥75th percentile) prices were larger (median 150 vs. 59 beds, p < 0.001) and more likely to be for-profit (31.2% vs. 7.8%, p < 0.001), academic-affiliated (52.7% vs. 23.1%, p < 0.001), and located in an urban zip code (70.1% vs. 41.3%, p < 0.001). From October 2022 to April 2023, the median self-pay price of vasectomy increased by 10% (from $1667 to $1832) while the median self-pay price of vasovasotomy decreased by 16% (from $3309 to $2786).Conclusion: We found large variability in self-pay pricing for vasectomy and vasectomy reversal, which may serve as a barrier to the accessibility of male reproductive care.","PeriodicalId":47632,"journal":{"name":"Perspectives on Sexual and Reproductive Health","volume":" ","pages":"98-105"},"PeriodicalIF":3.4000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Perspectives on Sexual and Reproductive Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/psrh.12266","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/23 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"DEMOGRAPHY","Score":null,"Total":0}

引用次数: 0

Abstract

Context: In the United States (US) men who undergo vasectomy and/or vasectomy reversal (vasovasotomy) are likely to pay out-of-pocket for these procedures. We characterized the publicly disclosed pricing of both procedures with a focus on variability in self-pay prices.

Methods: We queried all US hospitals for publicly disclosed prices of vasectomy and vasovasotomy. We assessed interhospital variability in self-pay pricing and compared hospitals charging high (≥75th percentile) and low (≤25th percentile) self-pay prices for either procedure. We also examined trends in pricing after the 2022 US Supreme Court decision that allowed individual states to ban abortion.

Results: Of 6692 hospitals, 1375 (20.5%) and 281 (4.2%) disclosed self-pay prices for vasectomy and vasovasotomy, respectively. There was a 17-fold difference between the 10th and 90th percentile self-pay prices for vasectomy ($421-$7147) and a 39-fold difference for vasovasotomy ($446-$17,249). Compared with hospitals charging low (≤25th percentile) self-pay prices for vasectomy or vasovasotomy, hospitals charging high (≥75th percentile) prices were larger (median 150 vs. 59 beds, p < 0.001) and more likely to be for-profit (31.2% vs. 7.8%, p < 0.001), academic-affiliated (52.7% vs. 23.1%, p < 0.001), and located in an urban zip code (70.1% vs. 41.3%, p < 0.001). From October 2022 to April 2023, the median self-pay price of vasectomy increased by 10% (from $1667 to $1832) while the median self-pay price of vasovasotomy decreased by 16% (from $3309 to $2786).

Conclusion: We found large variability in self-pay pricing for vasectomy and vasectomy reversal, which may serve as a barrier to the accessibility of male reproductive care.

查看原文本刊更多论文

美国输精管结扎术和输精管结扎复通术的自费价格差异很大。

背景：在美国，接受输精管结扎术和/或输精管结扎复通术（输精管切开术）的男性很可能需要自付费用。我们对这两种手术公开披露的价格进行了分析，重点关注自费价格的变化：我们询问了所有美国医院公开披露的输精管结扎术和输精管切开术的价格。我们评估了医院间自费价格的差异，并对自费价格高（≥75百分位数）和自费价格低（≤25百分位数）的医院进行了比较。我们还研究了 2022 年美国最高法院做出允许各州禁止堕胎决定后的定价趋势：在 6692 家医院中，分别有 1375 家（20.5%）和 281 家（4.2%）披露了输精管结扎术和输精管切开术的自费价格。输精管结扎术自费价格的第 10 个百分点和第 90 个百分点之间相差 17 倍（421 美元-7147 美元），输精管切开术相差 39 倍（446 美元-17249 美元）。与输精管结扎术或输精管切开术自费价格低（≤第 25 个百分位数）的医院相比，自费价格高（≥第 75 个百分位数）的医院规模更大（中位数为 150 张床位对 59 张床位，P 结语）：我们发现输精管结扎术和输精管结扎复通术的自费价格差异很大，这可能成为男性生殖保健服务可及性的一个障碍。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Perspectives on Sexual and Reproductive Health Multiple-

CiteScore

5.10

自引率

3.40%

发文量

期刊介绍： Perspectives on Sexual and Reproductive Health provides the latest peer-reviewed, policy-relevant research and analysis on sexual and reproductive health and rights in the United States and other developed countries. For more than four decades, Perspectives has offered unique insights into how reproductive health issues relate to one another; how they are affected by policies and programs; and their implications for individuals and societies. Published four times a year, Perspectives on Sexual and Reproductive Health includes original research, special reports and commentaries on the latest developments in the field of sexual and reproductive health, as well as staff-written summaries of recent findings in the field.